Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Vance

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
The American Journal of Physiology|January 1, 1991
Temporal structure of in vivo growth hormone secretory events in humansM L Hartman, A C Faria, M L Vance, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1990
Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapyM L Hartman, J D Veldhuis, M L Vance, et al.
Pituitary|November 18, 2000
Estrogen receptors in prolactinomas: a clinico-pathological studyG J Kaptain, N E Simmons, T D Alden, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1989
Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boyM L Vance, D L Kaiser, P M Martha, et al.
The Journal of Clinical Investigation|May 1, 1985
Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretionM L Vance, D L Kaiser, W S Evans, et al.
Clinical Pharmacology and Therapeutics|December 1, 1986
The effect of intravenous, subcutaneous, and intranasal GH-RH analog, [Nle27]GHRH(1-29)-NH2, on growth hormone secretion in normal men: dose-response relationshipsM L Vance, W S Evans, D L Kaiser, et al.
Hormone Research|January 1, 1986
Clinical studies with GHRH in manM O Thorner, M L Vance, W S Evans, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 9, 2006
The reliability and validity of the impact on lifestyle questionnaire in patients with acromegalyW R Lenderking, C Zacker, L Katznelson, et al.
The Journal of Clinical Investigation|July 1, 1984
Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuationC B Webb, M L Vance, M O Thorner, et al.
The Journal of Clinical Investigation|May 1, 1984
Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in manL A Frohman, J L Thominet, C B Webb, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
The American Journal of Physiology|January 1, 1991
Temporal structure of in vivo growth hormone secretory events in humansM L Hartman, A C Faria, M L Vance, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1990
Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapyM L Hartman, J D Veldhuis, M L Vance, et al.
Pituitary|November 18, 2000
Estrogen receptors in prolactinomas: a clinico-pathological studyG J Kaptain, N E Simmons, T D Alden, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1989
Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boyM L Vance, D L Kaiser, P M Martha, et al.
The Journal of Clinical Investigation|May 1, 1985
Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretionM L Vance, D L Kaiser, W S Evans, et al.
Clinical Pharmacology and Therapeutics|December 1, 1986
The effect of intravenous, subcutaneous, and intranasal GH-RH analog, [Nle27]GHRH(1-29)-NH2, on growth hormone secretion in normal men: dose-response relationshipsM L Vance, W S Evans, D L Kaiser, et al.
Hormone Research|January 1, 1986
Clinical studies with GHRH in manM O Thorner, M L Vance, W S Evans, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 9, 2006
The reliability and validity of the impact on lifestyle questionnaire in patients with acromegalyW R Lenderking, C Zacker, L Katznelson, et al.
The Journal of Clinical Investigation|July 1, 1984
Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuationC B Webb, M L Vance, M O Thorner, et al.
The Journal of Clinical Investigation|May 1, 1984
Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in manL A Frohman, J L Thominet, C B Webb, et al.
Pageof 9